Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 17 of 31

COMPLETED

Glenoid Bone Grafting for RTSA: Clinical & Radiographic Outcomes

NCT03151109
COMPLETED

Brain Health and Development With T1DM

NCT03335878
COMPLETED NA

Shared Decision Making to Improve Palliative Care in the Nursing Home

NCT02917603
COMPLETED NA

"Working for You" Workplace Obesity Intervention

NCT02934113
COMPLETED NA

Using Self-Motivating Messages to Encourage People to Exercise More

NCT02903849
COMPLETED Phase 4

Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training

NCT03272711
COMPLETED NA

CSF Pharmacokinetics of Ondansetron

NCT02901054
COMPLETED Phase 2

Temozolomide Chronotherapy for High Grade Glioma

NCT02781792
COMPLETED

NANOTECH RCC Biomarkers

NCT02923284
TERMINATED Phase 2

fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI

NCT02980484
TERMINATED NA

Exercise Training to Improve Brain Health in Older HIV+ Individuals

NCT02663934
COMPLETED NA

Patient Positioning and Airway Management During ERCP

NCT02850887
TERMINATED NA

Improving Mental and Physical Health and Decreasing Hospital Readmission After Pancreatectomy Through Enhanced Patient and Caregiver Education and Engagement

NCT02617979
COMPLETED NA

Raising Well at Home

NCT04224623
COMPLETED Phase 2

Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer

NCT02643667
COMPLETED Phase 1

Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia

NCT02919618
TERMINATED Phase 1

Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation

NCT02750254
COMPLETED Phase 4

Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients

NCT02926573
COMPLETED Phase 1

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

NCT02715609
TERMINATED Phase 2

Shave Margins in Breast Conservation Therapy

NCT02462200
COMPLETED NA

Adaptation of the STEPPING ON Fall Prevention Program for Older Adults Receiving Cancer Therapy

NCT02737839
COMPLETED Phase 1

Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers

NCT02642809
COMPLETED Phase 1

Epidural Analgesia Use in Pancreatic Resections

NCT02681796
TERMINATED Phase 1

BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer

NCT02608229
COMPLETED NA

Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)

NCT03636568
COMPLETED Phase 1

Buprenorphine Used With Treatment Resistant Depression in Older Adults

NCT02181231
COMPLETED NA

Oxygen for Intrauterine Resuscitation of Category II Fetal Heart Tracings

NCT02741284
TERMINATED Phase 4

Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis

NCT02769702
COMPLETED Phase 2

Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum

NCT02641691
COMPLETED

Investigating the Neurobiology of Tinnitus

NCT01294124
COMPLETED NA

Peak Plantar Pressures While Wearing a Carbon Fiber Off Loading Orthoses

NCT03618628
COMPLETED NA

A Comparison of Short Interval vs. Routine Postpartum Visit on Contraceptive Initiation

NCT02769676
COMPLETED NA

The Role of Brown Adipose Tissue in Triglyceride Clearance in People

NCT02786251
TERMINATED Phase 1

Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease

NCT02678143
COMPLETED Phase 1

Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma

NCT02728531
COMPLETED Phase 2

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

NCT02573493
COMPLETED NA

Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia

NCT02669836
COMPLETED NA

Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia

NCT02761330
TERMINATED NA

Reducing Readmissions in High-Risk Ostomates

NCT02658123
COMPLETED Phase 2

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

NCT02639559
TERMINATED Early Phase 1

Nitrous TRD Bipolar Depression

NCT02757521
COMPLETED NA

Healthy and Affordable Protein Rich Foods for African Market

NCT02757508
COMPLETED Phase 1

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

NCT02717572
COMPLETED

Coxsackie Virus in Pregnancy and Congenital Heart Disease

NCT03737006
COMPLETED NA

Pilot Trial of External Warming in Septic Patients

NCT02706275
COMPLETED NA

Effects of a Calorie Restricted, Very Low Fat Plant-based Diet and Multi-component Exercise Program on Metabolic Health

NCT02706288
COMPLETED NA

Metatarsal Phalangeal Joint Deformity Progression - R01

NCT02616263
TERMINATED Phase 4

Analgesic Efficacy of Liposomal Bupivacaine vs. Bupivacaine HCL as a Tap Block After Abdominally Based Autologous Breast Reconstruction

NCT02662036
COMPLETED Phase 2

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

NCT02584309
COMPLETED Phase 1

MK-3475 Immunotherapy in Endometrial Carcinoma

NCT02630823
← Previous Page 17 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

Therapeutic Areas

Obesity 20
Breast Cancer 19
Multiple Myeloma 13
Myelodysplastic Syndromes 13
Alzheimer Disease 10
Parkinson Disease 8
Depression 8
Cancer of the Breast 7
Dementia 7
Insulin Resistance 7

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.